05/12/2025
The GLP-1 Revolution: What Patients Really Need to Know
GLP-1 medications like Ozempic, Wegovy, and Mounjaro are transforming how we treat diabetes and obesity. These drugs mimic a natural hormone that reduces hunger, slows stomach emptying, and improves insulin response—leading to better sugar control and 15–20% weight loss for many patients.
Beyond weight, research shows benefits for the heart and kidneys, making them valuable for patients with diabetes and metabolic risk.
But they’re not perfect. Early side effects like nausea, vomiting, and digestive issues are common but usually settle. Rare risks include pancreatitis and gallbladder problems. And yes—concerns about thyroid cancer remain theoretical, not proven in humans.
📌 Who may benefit:
• Type 2 diabetes with poor control
• Obesity (BMI >30) or obesity-related conditions
• High cardiovascular risk
⚠️ Who should be cautious:
History of pancreatitis, thyroid disease, pregnancy, or severe GI issues.
💰 Cost in India: ₹5,000–₹30,000/month depending on dose and brand.
🎯 Bottom Line
GLP-1 drugs are powerful tools—not magic solutions. They work best with the right lifestyle changes and proper medical supervision. For the right patient, they can be life-changing.
If you’re struggling with weight or diabetes, speak with a qualified specialist to understand whether GLP-1 therapy is right for you.
📞 Sterling Hospitals, Vadodara
👨⚕️ Dr Samir Contractor — Senior Consultant, Laparoscopic & Bariatric Surgery